Mission Creek Capital Partners, Inc. 10x Genomics, Inc. Transaction History

Mission Creek Capital Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $2.91 Million - $3.84 Million	-20,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $2.28 Million - $3.43 Million	16,956 Added 557.03%	20,000 $3.92 Million
Q1 2021 May 14, 2021	SELL	$140.25 - $196.86 $6.29 Million - $8.83 Million	-44,857 Reduced 93.65%	3,044 $551,000
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $5.57 Million - $7.22 Million	44,077 Added 1152.64%	47,901 $6.78 Million
Q3 2020 Nov 13, 2020	BUY	$87.44 - $125.0 $334,370 - $478,000	3,824 New	3,824 $477,000
Q2 2020 Aug 14, 2020	SELL	$58.39 - $89.31 $231,107 - $353,488	-3,958 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $204,114 - $422,001	3,958 New	3,958 $247,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.